Literature DB >> 26834142

Epigenetics and Human Disease.

Huda Y Zoghbi1, Arthur L Beaudet2.   

Abstract

Genetic causes for human disorders are being discovered at an unprecedented pace. A growing subclass of disease-causing mutations involves changes in the epigenome or in the abundance and activity of proteins that regulate chromatin structure. This article focuses on research that has uncovered human diseases that stem from such epigenetic deregulation. Disease may be caused by direct changes in epigenetic marks, such as DNA methylation, commonly found to affect imprinted gene regulation. Also described are disease-causing genetic mutations in epigenetic modifiers that either affect chromatin in trans or have a cis effect in altering chromatin configuration.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26834142      PMCID: PMC4743078          DOI: 10.1101/cshperspect.a019497

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  189 in total

1.  A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus.

Authors:  W C Forrester; E Epner; M C Driscoll; T Enver; M Brice; T Papayannopoulou; M Groudine
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

Review 2.  Epigenetic and genetic diagnosis of Silver-Russell syndrome.

Authors:  Thomas Eggermann; Sabrina Spengler; Magdalena Gogiel; Matthias Begemann; Miriam Elbracht
Journal:  Expert Rev Mol Diagn       Date:  2012-06       Impact factor: 5.225

3.  Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.

Authors:  F L Sun; W L Dean; G Kelsey; N D Allen; W Reik
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  Chondroitin-6-sulphaturia, defective cellular immunity, and nephrotic syndrome.

Authors:  R N Schimke; W A Horton; C R King
Journal:  Lancet       Date:  1971-11-13       Impact factor: 79.321

6.  The fragile X: a scanning electron microscope study.

Authors:  C J Harrison; E M Jack; T D Allen; R Harris
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

7.  Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.

Authors:  Saurabh K Garg; Daniel T Lioy; Hélène Cheval; James C McGann; John M Bissonnette; Matthew J Murtha; Kevin D Foust; Brian K Kaspar; Adrian Bird; Gail Mandel
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

8.  Adult neural function requires MeCP2.

Authors:  Christopher M McGraw; Rodney C Samaco; Huda Y Zoghbi
Journal:  Science       Date:  2011-06-02       Impact factor: 47.728

9.  Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer.

Authors:  Tamara Hansmann; Galyna Pliushch; Monika Leubner; Patricia Kroll; Daniela Endt; Andrea Gehrig; Sabine Preisler-Adams; Peter Wieacker; Thomas Haaf
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

10.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.

Authors:  Kathryn Blaschke; Kevin T Ebata; Mohammad M Karimi; Jorge A Zepeda-Martínez; Preeti Goyal; Sahasransu Mahapatra; Angela Tam; Diana J Laird; Martin Hirst; Anjana Rao; Matthew C Lorincz; Miguel Ramalho-Santos
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962

View more
  63 in total

Review 1.  The genetic basis of disease.

Authors:  Maria Jackson; Leah Marks; Gerhard H W May; Joanna B Wilson
Journal:  Essays Biochem       Date:  2018-12-02       Impact factor: 8.000

Review 2.  Targeting the epigenome in malignant pleural mesothelioma.

Authors:  Kaitlin C McLoughlin; Andrew S Kaufman; David S Schrump
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  Epigenetics and autism spectrum disorder: A report of an autism case with mutation in H1 linker histone HIST1H1E and literature review.

Authors:  Lara J Duffney; Purnima Valdez; Martine W Tremblay; Xinyu Cao; Sarah Montgomery; Allyn McConkie-Rosell; Yong-Hui Jiang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-27       Impact factor: 3.568

Review 4.  Dad's Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders.

Authors:  Daniela Morales-Lara; Clelia De-la-Peña; Eric Murillo-Rodríguez
Journal:  Mol Neurobiol       Date:  2017-02-02       Impact factor: 5.590

Review 5.  Connecting the Dots Between Fatty Acids, Mitochondrial Function, and DNA Methylation in Atherosclerosis.

Authors:  Silvio Zaina; Gertrud Lund
Journal:  Curr Atheroscler Rep       Date:  2017-09       Impact factor: 5.113

Review 6.  Epigenetic regulation in plants.

Authors:  Craig S Pikaard; Ortrun Mittelsten Scheid
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-01       Impact factor: 10.005

Review 7.  Epigenetic mechanisms of drug resistance in fungi.

Authors:  Zanetta Chang; Vikas Yadav; Soo Chan Lee; Joseph Heitman
Journal:  Fungal Genet Biol       Date:  2019-07-17       Impact factor: 3.495

Review 8.  The interplay of epigenetic marks during stem cell differentiation and development.

Authors:  Yaser Atlasi; Hendrik G Stunnenberg
Journal:  Nat Rev Genet       Date:  2017-08-14       Impact factor: 53.242

Review 9.  Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.

Authors:  Linda Sommese; Alberto Zullo; Francesco Paolo Mancini; Rossella Fabbricini; Andrea Soricelli; Claudio Napoli
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

Review 10.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.